Document is current

Article History

Received: 6 October 2020

Accepted: 26 December 2020

First Online: 7 January 2021

Ethics approval and consent to participate

: All patients provided written informed consent. The study was approved by the institutional review board at each participating center.

: Not applicable.

: Akiko Maehara: Grant support from Abbott Vascular and Boston Scientific, consultant for Conavi Medical Inc. Bernard De Bruyne: Institutional grant support from Abbott, Boston Scientific, and Biotronik AG; institutional consulting fees from Abbott, Opsens, and Boston Scientific. Roxana Mehran: Institutional Grant Support (funding to the institution)—AstraZeneca, Bayer, Beth Israel Deaconess, BMS, CSL Behring, DSI, BSC, Novartis Pharmaceuticals, OrbusNeich; Consulting Fees—Medscape, Regeneron Pharmaceuticals (no fee, Sanofi, Abbott Laboratories (personal fees for speaking engagements; consultant (paid to the institution), Abiomed and The Medicines Company (consultant – spouse); Scientific Advisory Board/Advisory Board—PLx Opco Inc./PLx Pharma Inc. (scientific advisory board), Bristol Myers Squibb (advisory board; funding to the institution); Equity < 1%—Claret Medical, Elixir Medical; Executive Committee (paid to the institution)—Janssen Pharmaceuticals; DSMB Membership—Watermark Research Partners. Patrick W. Serruys: Consultant – Abbott, Biosensors, Medtronic, Micell Technologies, SINOMED, Philips/Volcano, Xeltis, HeartFlow. Gary S. Mintz: Honoraria—Boston Scientific, Philips, Terumo, and Medtronic. The rest of the authors: none.